Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative

Details for Australian Patent Application No. 2008288407 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Dugi, Klaus; Thomas, Leo; Mark, Michael; Himmelsbach, Frank

Agent Davies Collison Cave

Pub. Number AU-B-2008288407

PCT Pub. Number WO2009/022007

Priority 07114459.6 16.08.07 EP

Filing date 15 August 2008

Wipo publication date 19 February 2009

Acceptance publication date 5 April 2012

International Classifications

A61K 31/00 (2006.01)

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7034 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/022007 Priority application(s): WO2009/022007

5 April 2012 Application Accepted

  Published as AU-B-2008288407

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008288410-Pharmaceutical composition comprising a SGLT2 inhibitor in combination with a DPP-IV inhibitor

2008288403-Device and procedure for the diagnosis or diagnostic preparation and/or therapy monitoring of inflammatory diseases such as rheumatoid arthritis